Phospholipase Cγ1 is essential for T cell development, activation, and tolerance by Fu, Guoping et al.
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 207 No. 2  309-318
www.jem.org/cgi/doi/10.1084/jem.20090880
309
Brief Definitive Report
During thymic T cell development, CD4+CD8+ 
double-positive (DP) thymocytes that express 
functional TCR are subjected to positive or 
negative  selection  and  mature  into  CD4  or 
CD8 single-positive (SP) thymocytes (Starr et al., 
2003).  Thymic  selection  also  leads  to  the   
development of FoxP3+ T regulatory (T reg) 
cells, which play a critical role in maintaining 
self-tolerance (Fontenot et al., 2003; Hori et al., 
2003;  Khattri  et  al.,  2003).  A  major  drive   
for thymic and mature T cell development are 
signals emanating from the TCR (Samelson, 
2002). PLC1 is an essential effector molecule 
in TCR signal transduction, which, after activa-
tion, hydrolyzes the membrane lipid phospha-
tidylinositol 4,5-bisphosphate (PIP2) to generate 
diacylglycerol  (DAG)  and  inositol  1,4,5-tri-
sphosphate (IP3; Rhee, 2001). Whereas DAG 
activates  the  NF-B  and  GRP–Ras–ERK 
pathways (Ebinu et al., 2000; Lin and Wang, 
2004),  IP3  mediates  the  elevation  of  Ca2+, 
which is essential for NFAT activation (Rao 
et al., 1997). The capability of PLC1 to regulate 
multiple signaling pathways and transcription 
factors raises considerable interest in the bio-
logical role of PLC1. However, embryonic 
lethality  of  PLC1-deficient  mice  precludes 
the analysis to determine the role of PLC1 in 
T cell biology in vivo (Ji et al., 1997). Here, we 
generate conditional PLC1-deficient mice, in 
which PLC1 deficiency is restricted to the T 
cell lineage. Our results demonstrate that PLC1 
plays a critical and as yet unknown multifold 
role in T cell biology.
RESULTS AND DISCUSSION
Generation of PLC1-deficient mice
To avoid embryonic lethality caused by PLC1 
deficiency, we modified PLC1 locus by “flox-
ing” exons 2–4 of PLC1 (Fig. S1). The offspring 
that inherited the “floxed” PLC1 (PLC1fl/+) 
were bred with PLC1+/ mice (Ji et al., 1997). 
CD4Cre (Cre) transgene was introduced into 
the PLC1fl/ mice to mediate PLC1 dele-
tion at thymic DP stage (Lee et al., 2001). 
PLC1 proteins were absent or substantially 
reduced in DP and SP thymocytes, and splenic 
T cells from Cre/PLC1fl/ compared with 
Cre/PLC1+/ mice (Fig. S2 A), and truncated 
PLC1 was not generated (not depicted). The 
residual PLC1 proteins in peripheral T cells 
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Phospholipase C1 (PLC1) is an important signaling effector of T cell receptor (TCR).  
To investigate the role of PLC1 in T cell biology, we generated and examined mice with  
T cell–specific deletion of PLC1. We demonstrate that PLC1 deficiency affects positive 
and negative selection, significantly reduces single-positive thymocytes and peripheral T cells, 
and impairs TCR-induced proliferation and cytokine production, and the activation of ERK, 
JNK, AP-1, NFAT, and NF-B. Importantly, PLC1 deficiency impairs the development and 
function of FoxP3+ regulatory T cells, causing inflammatory/autoimmune symptoms. There-
fore, PLC1 is essential for T cell development, activation, and tolerance.
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and CD4+CD8CD69+YFP+ thymocytes from Cre/YFP/
PLC1fl/ relative to Cre/YFP/PLC1+/ mice (Fig. 1 B). 
Thus, PLC1 deficiency impaired the development of the 
bipotent CD4+CD8lo thymocytes, and further development of 
both CD4 and CD8 thymocytes. In addition, PLC1 defi-
ciency reduced the up-regulation of Th-POK in CD4+CD8lo 
and CD4+CD8 thymocytes, providing one possible ex-
planation for the greater affect on the CD4SP population. 
Finally, compared with Cre/YFP/PLC1+/ mice, Cre/YFP/
PLC1fl/ mice lacked a small population of DP thymocytes 
that up-regulated CD3 and CD69 (Fig. 1 C), and had reduced 
CD5 up-regulation on DP thymocytes and CD3, CD5, and 
CD69 up-regulation on SP thymocytes (Fig. 1 C). These data 
are consistent with the notion that PLC1 deficiency reduces 
TCR signaling.
As PLC1 deficiency resulted in reduction of SP thy-
mocytes, we further examined the role of PLC1 in thymic 
positive and negative selection using HY TCR transgenic 
mice. Each experimental mouse carried a single copy of the 
HY transgene. Positive selection in female Cre/PLC1+//
HY mice resulted in high CD8SP thymocyte percentages in 
total (20 ± 8.2%) and T3-70hi (54 ± 12%) cells (Fig. 1 D). 
In  contrast,  female  Cre/PLC1fl//HY  mice  displayed  a 
significant reduction in CD8SP thymocyte percentages in 
total (2.8 ± 0.66%, P = 0.02) and T3-70hi (19 ± 9.0%, P = 
0.01) cells. Therefore, PLC1 deficiency blocks positive se-
lection. In male Cre/PLC1+//HY mice, negative selec-
tion significantly reduced thymic cellularity (3.8 ± 2.0 × 
106)  and  DP  thymocyte  percentages  within  total  (6.3  ± 
4.0%) and T3-70hi (2.3 ± 1.3%) cells, with an increase in 
DN thymocyte percentages within total (79 ± 4.0%) and 
T3-70hi (85 ± 6.2%) cells (Fig. 1 E). In comparison, male 
Cre/PLC1fl//HY mice had a markedly increased thymic 
of Cre/PLC1fl/ mice may reflect preferential survival 
and/or amplification of rare thymocytes that failed to delete 
the PLC1 gene. To better track deletion of the “floxed” 
PLC1, we used Rosa-26-YFP (YFP) mice (Srinivas et al., 
2001). PLC1 expression was not observed in YFP+ thymo-
cytes and splenic T cells (Fig. S2 B). Thus, YFP expression 
correlates with Cre-mediated deletion of the floxed PLC1 
in T cells.
PLC1 deficiency impairs thymocyte maturation
We examined T cell development in Cre/PLC1fl/ mice. 
PLC1+/,  PLC1fl/,  and  Cre/PLC1+/  mice  showed 
normal  T  cell  development  compared  with  WT  mice, 
and thus served as experimental controls (Table I and not 
depicted). Total thymocyte number of Cre/PLC1fl/ mice 
was reduced compared with that of the control mice, but 
not statistically significant (Table I). Whereas the percent-
age of DN thymocytes was not significantly changed, the 
percentage of DP thymocytes was slightly but consistently 
increased in Cre/PLC1fl/ mice relative to controls (Table I). 
Moreover, there was a dramatic reduction in the percent-
ages and absolute numbers of SP thymocytes derived from 
Cre/PLC1fl/ mice relative to controls, with CD4SP thy-
mocytes more profoundly affected than CD8SP thymocytes 
(Table I). Further analysis showed that the percentage of the 
“bipotent” CD4+CD8loYFP+ thymocytes that differentiate 
into either CD4 or CD8 SP thymocytes was reduced by 
55 ± 16% in Cre/YFP/PLC1fl/ mice compared with Cre/
YFP/PLC1+/ mice. The percentage of CD4+CD8YFP+ 
thymocytes  was  further  reduced  by  82  ±  5%  (Fig.  1  A). 
Importantly, expression of Th-POK, the transcription fac-
tor  that  determines  CD4  T  cell  commitment  (He  et  al., 
2005), was significantly lower in CD4+CD8loCD69+YFP+ 
Table I.  Analysis of T cell populations in Cre/PLC1fl/ and the control mice
Thymocytes Splenocytes
Total DN DP CD4 SP CD8 SP Total CD4+ CD8+
PLC1+/ 
(n = 6)
% 1.5 ± 0.8 87 ± 2.8 8.5 ± 1.5 2.7 ± 1.2 22 ± 3.6 15 ± 2.9
# (×106) 216 ± 76 3.2 ± 2.0 189 ± 69 19 ± 8.3 6.4 ± 4.1 100 ± 46 22 ± 11 15 ± 6.6
PLC1fl/ 
(n = 6)
% 1.1 ± 0.7 87 ± 4.1 9.4 ± 2.1 2.8 ± 1.5 18 ± 8.7 12 ± 5.1
# (×106) 238 ± 61 2.6 ± 1.5 223 ± 40 24 ± 6.4 6.9 ± 3.4 93 ± 42 17 ± 11 11 ± 7.6
Cre/PLC1+/ 
(n = 8)
% 2 ± 0.8 87 ± 1.5 8.3 ± 1.5 2.9 ± 1.0 15 ± 5.3 12 ± 4.0
# (×106) 201 ± 88 3.6 ± 1.5 174 ± 72 17 ± 8.3 6.0 ± 4.0 118 ± 46 18 ± 8.6 13 ± 6.6
Cre/PLC1fl/ 
(n = 9)
% 2.1 ± 1.2 95 ± 2.3a 1.5 ± 0.43a 1.2 ± 0.9b 3.2 ± 1.5a 5.6 ± 1.8c
# (×106) 172 ± 81 3.7 ± 2.8 170 ± 72 2.7 ± 1.7c 2.3 ± 2.0d 77 ± 27 2.7 ± 2c 4.1 ± 2.8b
The age of the mice analyzed was between 3 and 10 wk. Data presented are average percentage (%) or absolute number (#) of each T cell subset. 
The P value was calculated by comparing the percentages or absolute numbers of different T cell subsets from Cre/PLC1fl/ mice to those from Cre/
PLC1+/ mice. There was no significant difference in the percentages and absolute numbers of different T cell subsets from PLC1+/, PLC1fl/, and 
Cre/PLC1+/ mice.
aP < 0.0001.
bP < 0.01.
cP < 0.001.
dP < 0.05.JEM VOL. 207, February 15, 2010  311
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data indicated a failure of negative selection and possible con-
version to positive selection in the absence of PLC1.
PLC1 deficiency results in peripheral T cell lymphopenia
Cre/PLC1fl/ mice had substantial reduction in peripheral 
T cells (Fig. 2 A and Table I). YFP+ percentage was also sub-
stantially  reduced  in  T  cells  from  Cre/YFP/PLC1fl/ 
(CD4+: 57 ± 5.1%; CD8+: 78 ± 9.2%) relative to Cre/YFP/
cellularity (11 ± 4.6 × 106, P = 0.01) and DP thymocyte per-
centages within total (42 ± 11%, P < 0.001) and T3-70hi (15 ± 
7.7%, P < 0.01) cells, with a reduction in DN thymocyte 
percentages within total (45 ± 9.8%, P < 0.001) and T3-70hi 
(68 ± 9.4%, P < 0.01) cells (Fig. 1 E). In addition, the CD8SP 
cells in the T3-70hi population was increased in male Cre/
PLC1fl//HY mice (14 ± 2.6%) compared with male Cre/
PLC1+//HY mice (8.7 ± 3.4%, P = 0.01; Fig. 1 E). These 
Figure 1.  PLC1 deficiency impairs thymocyte maturation. (A) PLC1 deficiency reduced the percentages of CD4+CD8lo and CD4+CD8 thymocytes. 
Data represent six pairs of mice. (B) PLC1 deficiency reduced Th-POK expression in CD4+CD8loCD69+ and CD4+CD8CD69+ thymocytes. Data represent 
two independent experiments on four Cre/YFP/PLC1fl/ and four Cre/YFP/PLC1+/ mice. (C) PLC1 deficiency reduced CD3, CD5, and CD69 expression 
levels on DP and SP thymocytes. Data represent three pairs of mice. (D) PLC1 deficiency blocks positive selection. CD4/CD8 expression profiles on total or 
T3-70hi thymocytes from female Cre/PLC1+//HY and Cre/PLC1fl//HY mice. Data represent three pairs of mice. (E) PLC1 deficiency impairs negative 
selection. CD4/CD8 expression profiles on total or T3-70hi thymocytes from male Cre/PLC1+//HY and Cre/PLC1fl//HY mice. Data represent five Cre/
PLC1+//HY and six Cre/PLC1fl//HY mice.312 PLC1 in TCR signal transduction | Fu et al.
PLC1 is essential for TCR-mediated proliferation  
and cytokine production
T cells from Cre/YFP/PLC1fl/ mice exhibited dramatic 
reduction of proliferation in response to stimulation with anti-
CD3,  anti-CD3/anti-CD28,  or  anti-CD3/IL-2  compared 
with those from Cre/YFP/PLC1+/ mice, and this reduc-
tion  was  largely  restored  by  PMA/ionomycin  stimulation 
(Fig. 3 A). Therefore, PLC1 is critical for TCR-mediated 
proliferation. In addition, compared with those from Cre/
YFP/PLC1+/  mice,  T  cells  from  Cre/YFP/PLC1fl/ 
mice (n = 3) displayed significant reduction in anti-CD3/anti-
CD28–induced  IL-2  production  by  CD4+  (Cre/YFP/
PLC1+/: mean fluorescence intensity (MFI) = 1741 ± 80; 
Cre/YFP/PLC1fl/: MFI = 899 ± 98, P < 0.01) and CD8+ 
(Cre/YFP/PLC1+/:  MFI  =  1685  ±  69;  Cre/YFP/
PLC1fl/: MFI = 1102 ± 119, P < 0.01) T cells (Fig. 3 B). 
The percentages of IFN-+ T cells from Cre/YFP/PLC1fl/ 
mice  after  anti-CD3/anti-CD28  stimulation  were  also  re-
duced,  but  not  significant  in  either  CD4+  (Cre/YFP/
PLC1+/: 25 ± 16%; Cre/YFP/PLC1fl/: 15 ± 2.5%, P = 
0.3) or CD8+ (Cre/YFP/PLC1+/: 54 ± 6.0%; Cre/YFP/
PLC1fl/: 38 ± 15%, P = 0.1) T cells (Fig. 3 B). Without 
differentiation, IL-4 was not detected in CD4+ T cells, re-
gardless of PLC1 expression (unpublished data). Therefore, 
whereas PLC1 deficiency significantly reduces IL-2 produc-
tion, it only slightly reduces IFN- production by T cells.
PLC1 deficiency impairs TCR signaling
We  further  examined  the  effect  of  PLC1  deficiency  on 
TCR-mediated  signaling.  Compared  with  Cre/PLC1+/ 
PLC1+/ mice (CD4+: 97 ± 1.3%, P < 0.001; CD8+: 98 ± 
1.1%, P < 0.001; Fig. 2 B), suggesting that PLC1 deficiency 
caused T cell incompetence. This possibility was supported 
by competitive BM transplantation experiments. When co-
transplanted with WT BM cells, Cre/YFP/PLC1fl/ BM 
cells, indicated by YFP expression, contributed significantly 
less to T cells than Cre/YFP/PLC1+/ BM cells, with pe-
ripheral  T  cells  more  severely  affected  than  thymocytes 
(Table S1). Together, these data indicated that PLC1-deficient 
thymocytes and peripheral T cells are less competent com-
pared with PLC1-sufficient T cells.
To examine the mechanism of T cell lymphopenia, we 
performed TUNEL and BrdU incorporation assays. T cells 
from Cre/PLC1fl/ and Cre/PLC1+/ mice showed com-
parable levels of TUNEL+ cells (unpublished data). Compared 
with Cre/PLC1+/ mice, Cre/PLC1fl/ mice contained 
higher  percentages  of  BrdU+  cells  in  SP  thymocytes  and 
splenic T cells (Fig. 2 C and not depicted), which could be 
caused by increased cell proliferation and/or apoptosis. Fur-
ther examination showed that Fas expression was increased 
on T cells from Cre/YFP/PLC1fl/ relative to Cre/YFP/
PLC1+/ mice (Fig. 2 D), whereas FasL expression was 
comparable (not depicted). In addition, reactivation resulted 
in significantly higher cell death in CD4+ T cells from Cre/
YFP/PLC1fl/ mice compared with Cre/YFP/PLC1+/ 
mice (Fig. 2 E), suggesting that PLC1-deficient T cells are 
more susceptible to activation-induced cell death (AICD), 
which is consistent with increased levels of Fas expression. 
Thus, increased AICD may contribute to T cell lymphopenia 
in PLC1-deficient mice.
Figure 2.  PLC1 deficiency results in T cell lymphopenia. (A) CD4/CD8 expression profiles on spleen and lymph node T cells from Cre/PLC1+/ and Cre/
PLC1fl/ mice. Data represent six pairs of mice. (B) Percentages of YFP+ cells in splenic CD4+ and CD8+ populations from Cre/YFP/PLC1+/ and Cre/YFP/PLC1fl/ 
mice. Data represent five pairs of mice. (C) PLC1-deficient peripheral T cells displayed higher rates of BrdU incorporation. Data represent three pairs of mice.  
(D) PLC1-deficient T cells showed increased Fas expression. Splenocytes from Cre/YFP/PLC1+/ (thin line) or Cre/YFP/PLC1fl/ (thick line) mice were examined 
for Fas expression. Dashed lines represent isotype control. Data represent four pairs of mice. (E) PLC1-deficient T cells are more susceptible to AICD. 7-AAD+ cells 
are examined in CD4+YFP+ populations. Each data point is the mean of data derived from three Cre/YFP/PLC1+/ or five Cre/YFP/PLC1fl/ mice. *, P < 0.01.JEM VOL. 207, February 15, 2010  313
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and not depicted). One third of Cre/PLC1fl/ mice devel-
oped variable visible symptoms, including alopecia, dermati-
tis, and rectal prolapse (symptomatic mice), with the latter 
two symptoms more frequent. Whereas none of the litter-
mate control mice exhibited significant histological abnor-
malities,  a  majority  of  symptomatic  Cre/PLC1fl/  mice 
showed infiltration of mononuclear cells into variable tissues, 
particularly skin and ear (Fig. 4 C). Although Cre/PLC1fl/ 
mice were severely T cell lymphopenic, the skin and ear were 
infiltrated by CD3+ T cells, which was not observed in the 
corresponding areas of the littermate control mice (Fig. 4 D). 
Serum  anti–double-stranded  DNA  antibodies  were  sig-
nificantly higher in symptomatic Cre/PLC1fl/ relative to 
nonsymptomatic Cre/PLC1fl/ or control mice (Fig. 4 E). 
Nevertheless, serum antinuclear antibodies were comparable 
(Fig. 4 E). The experimental mice analyzed were backcrossed 
with C57BL/6 mice for three generations. We have since de-
termined that Cre/PLC1fl/ mice backcrossed with C57BL/6 
mice, T cells from Cre/PLC1fl/ mice displayed markedly 
reduced TCR-induced Ca2+ flux, but higher basal Ca2+ level 
in the CD4SP thymocytes (Fig. 3 C). Although basal level ac-
tivities of ERK and JNK were high in T cells from Cre/
PLC1fl/ mice, TCR-mediated activation of these kinases 
was reduced compared with those from Cre/PLC1+/ mice 
(Fig. 3 D). Moreover, regardless of CD28 stimulation, TCR-
induced activation of transcription factors NFAT, NF-B, and 
AP-1 was severely impaired in T cells from Cre/PLC1fl/ 
relative to Cre/PLC1+/ mice (Fig. 3 E). Collectively, these 
data demonstrate that PLC1 plays a central role in TCR-
mediated activation of multiple signaling pathways.
PLC1-deficient mice develop inflammatory/ 
autoimmune disease
From 2–3 wk of age, most Cre/PLC1fl/ mice were appar-
ently runt (Fig. 4 A), with reduced weight in both male and 
female mice compared with littermate control mice (Fig. 4 B 
Figure 3.  The effect of PLC1 deficiency on proliferation, cytokine production, and TCR signaling. (A) PLC1 deficiency impairs TCR-mediated 
proliferation. (B) The effect of PLC1 deficiency on IL-2 and IFN- production. (C) PLC1 deficiency impairs TCR-mediated Ca2+ mobilization in both SP 
thymocytes and splenic T cells. (D) PLC1 deficiency impairs TCR-mediated ERK and JNK activation. (E) PLC1 deficiency impairs TCR-mediated AP-1, 
NFAT, and NF-B activation. All data shown are representative of three independent experiments. The numbers shown in B represent IFN-+ T cells from 
one pair of mice after anti-CD3/anti-CD28 stimulation.314 PLC1 in TCR signal transduction | Fu et al.
corrected in mice receiving Cre/YFP/PLC1fl/ and WT 
BM cells (Fig. S3). Thus, T cell lymphopenia may contribute 
to the activated T cell phenotype in PLC1-deficient mice. 
Alternatively,  given  that  the  symptoms  of  Cre/PLC1fl/ 
mice are reminiscent of mice deficient in FoxP3+ T reg cells 
(Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 2003), 
the autoimmune phenotype may be consequent to impaired 
T reg cells. The percentage and absolute number of T reg 
cells were substantially reduced in thymus in Cre/PLC1fl/ 
relative to Cre/PLC1+/ mice (Fig. 5, B and C). Although 
T reg cell percentage was reduced in lymphocytes in the 
spleen and lymph nodes of Cre/PLC1fl/ relative to Cre/ 
PLC1+/ mice, it was substantially increased in CD4+ T cells 
mice for eight generations displayed the same phenotypes 
(unpublished data). Although we cannot entirely exclude back-
ground gene effects, we can conclude that the inflammatory/
autoimmune syndrome in Cre/PLC1fl/ mice is attribut-
able to PLC1 deficiency.
PLC1 deficiency impairs T reg cell development  
and function
T cells in Cre/YFP/PLC1fl/ mice showed activated phe-
notype, including larger cell sizes, decreased CD62L, and 
increased CD44 expression compared with those in Cre/
YFP/PLC1+/ mice (Fig. 5 A). T cell lymphopenia and the 
activated phenotype of PLC1-deficient T cells were largely 
Figure 4.  Cre/PLC1fl/ mice develop inflammatory/autoimmune disease. (A) Cre/PLC1fl/ mice were smaller than littermate control mice. A pair 
of 6-wk-old littermates is shown. (B) PLC1 deficiency reduced weight gain in Cre/PLC1fl/ mice. Each point represents the mean weight of 7 to 14  
female mice. *: P < 0.05. (C) Infiltration of inflammatory cells in the skin and ear (H&E, x200) of Cre/PLC1fl/ mice. Bar, 100 µm. (D) Infiltration of CD3+  
T cells in the skin and ear (x200) of Cre/PLC1fl/ mice. The slides were analyzed by immunohistochemistry and examined by Nikon Eclipse E600. Bar,  
100 µm. (E) Levels of -double-stranded DNA antibodies and antinuclear antibodies in the serum of symptomatic Cre/PLC1fl/ mice compared with the  
indicated control mice.JEM VOL. 207, February 15, 2010  315
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T reg cell development and functions, which may contrib-
ute to the inflammatory/autoimmune disease in the PLC1- 
deficient mice.
The  development  of  inflammatory/autoimmunity  in 
Cre/PLC1fl/ mice could be attributed to a couple of possi-
bilities. First, impairment of thymic negative selection allows 
autoreactive thymocytes that would normally be eliminated, 
to survive and mature into periphery and become pathogenic 
T cells. To determine whether PLC1 deficiency altered the 
T cell TCR repertoire, we performed spectratyping analysis 
of 18 V subfamilies (Mas ´lanka et al., 1995) on cDNA iso-
lated  from  Cre/YFP/PLC1fl/  and  Cre/YFP/PLC1+/ 
thymocytes. The CD4SPYFP+ cells from either of the mice 
showed a Gaussian distribution of CDR3 length commensu-
rate with normal selection (unpublished data). Interestingly, 
the CDR3 length profiles of CD8SPYFP+ cells from Cre/
(Fig. 5 B). Nevertheless, T reg cell number was dramati-
cally reduced in the spleen from Cre/PLC1fl/ relative to 
Cre/PLC1+/ mice (Fig. 5 C). We performed suppression 
assays to determine T reg cell suppressive functions. Com-
pared with those from Cre/YFP/PLC1+/ mice, YFP+ T 
reg cells from Cre/YFP/PLC1fl/ mice had reduced abil-
ity to suppress naive T cell proliferation (Fig. 5 D). Fur-
thermore, we transferred purified WT T reg cells into 10 
10-d-old Cre/YFP/PLC1fl/ mice to determine whether 
impaired T reg cells contributed to the disease phenotype in 
PLC1-deficient mice. None of them developed symptoms 
such as alopecia, dermatitis, and rectal prolapse. These mice 
gained weight at a rate similar to WT mice (Fig. 5 E). WT 
T reg cells also partially corrected the activated phenotype of 
Cre/YFP/PLC1fl/ T cells, as CD62L expression was in-
creased (Fig. 5 F). Collectively, PLC1 deficiency impaired 
Figure 5.  PLC1 deficiency impairs T reg cell development and function. (A) PLC1-deficient T cells display activated phenotype. Data are repre-
sentative of four pairs of mice. (B) Percentages of FoxP3+ T reg cells in total and CD4-gated lymphocytes in the thymus, spleen, and lymph node cells. 
Data represent five pairs of mice. (C) CD4+FoxP3+ cell numbers were reduced in thymus and spleen of Cre/PLC1fl/ mice. Data represent five pairs of 
mice. (D) PLC1 deficiency impairs the inhibitory functions of T reg cells. Error bars represent the standard deviation of triplicate measurements of each 
data point. *: P < 0.05, **: P < 0.01. Data are representative of two independent experiments. (E) WT T reg cell reconstitution restores normal weight gain 
in Cre/PLC1fl/ mice. Each point represents the mean weight of 7 to 14 female Cre/PLC1+/ mice or 6 female Cre/PLC1fl/ mice that received WT T reg 
cells. (F) WT T reg cell reconstitution restores high CD62L expression on PLC1-deficient T cells. Data represent three independent experiments.316 PLC1 in TCR signal transduction | Fu et al.
into CD4 lineage. In contrast, attenuated TCR signaling as a 
result of CD8 expression loss, denoting MHC class I recogni-
tion, leads to CD8 T cell development. Our data showed that 
PLC1 is required for CD4+CD8lo thymocyte development 
as well as Th-POK expression in CD4+CD8lo and CD4+CD8 
thymocytes.  Consequently,  PLC1  deficiency  impairs  both 
CD4 and CD8 development with CD4 lineage more affected.
The reason for elevated basal calcium and MAPK activity 
is not clear. PLC1-deficient T cells had activated pheno-
type, which may account for elevated basal Ca2+ and MAPK 
activity. Our study showed that both lymphopenia and im-
paired T reg cells may contribute to the activated T cell phe-
notype.  In  addition,  Cbl-b  up-regulation  was  severely 
impaired in PLC1-deficient T cells (unpublished data). Sev-
eral studies have shown that Cbl-b plays an important role in 
down-regulating TCR expression and peripheral T cell acti-
vation (Bachmaier et al., 2000; Chiang et al., 2000; Naramura 
et al., 2002). In addition, a previous study showed that CD5 
deficiency enhances PLC1 activation (Tarakhovsky et al., 
1995). Thus, impaired CD5 up-regulation in PLC1-deficient 
T cells could enhance the activation of PLC2, which is in-
volved in TCR signal transduction. It is possible that enhanced 
basal level Ca2+ and Erk activation may be the consequence of 
peripheral lymphopenia, impaired T reg cell number/functions, 
and defective CD5 and Cbl up-regulation.
In conclusion, we observed that PLC1 deficiency severely 
impairs TCR-induced activation of multiple signaling mole-
cules and transcription factors, and unveiled a crucial role of 
PLC1 in T cell development, activation, and tolerance.
MATERIALS AND METHODS
Mice. HY TCR and CD4Cre transgenic mice were purchased from Taconic. 
PLC1+/ and Rosa-26-YFP mice were generously provided by G. Carpenter 
(Vanderbilt University, Nashville, TN; Ji et al., 1997) and F. Costantini 
(Columbia University, New York, NY; Srinivas et al., 2001), respectively. 
PLC1-deficient and control mice were originally on a mixed 129xC57BL/6 
background. The experimental mice were backcrossed onto the C57BL/6 
background for three generations. Mice analyzed were between 6 and 12 wk 
old unless otherwise stated. Mice were maintained in the Biological Resource 
Center at the Medical College of Wisconsin (MCW). All animal protocols 
were approved by the MCW Institutional Animal Care and Use Committee.
Cell  proliferation  and  intracellular  cytokine  analysis.  Splenocytes 
were labeled with PKH Fluorescent Cell Linker Dye (PKH26; Sigma-
Aldrich) according to the manufacturer’s recommendation and stimulated for 
72 h before analysis for cell proliferation. For intracellular cytokine staining, 
total splenocytes (1.5 × 106/ml) were stimulated for 36 h, followed by 6 h of 
monensin treatment. The cells were then harvested and stained with -CD4 
and -CD8 antibodies, followed by intracellular staining for IL-2, IL-4, and 
IFN- according to manufacture’s recommendation (eBioscience).
Real-time PCR analysis of Th-POK expression. CD4+CD8loCD69+YFP+ 
and CD4+CD8CD69+YFP+ thymocytes were purified from Cre/YFP/
PLC1fl/ and Cre/YFP/PLC1+/ mice and total RNA was extracted. 
Th-POK expression was examined by real-time PCR as previously de-
scribed (He et al., 2005).
Calcium flux analysis. Thymocytes or splenocytes (2 × 106) were loaded 
with indo-1AM in 1 ml PBS (2% FBS + 10 µg/ml indo-1AM) for 30 min. The 
cells were then incubated with FITC--CD4 + PE--CD8 + biotin--CD3 
YFP/PLC1fl/ mice differed from the Gaussian profile seen 
in the control PLC1+/ mice for several subfamilies exam-
ined (unpublished data). Thus, while PLC1 deficiency af-
fects the naive CD8 repertoire, the effect, if any, on naive 
CD4 repertoire involves more subtle changes that do not 
alter the overall distribution of CDR3 lengths. Second, 
impaired function of T regs in Cre/PLC1fl/ mice also con-
tribute to the autoimmune phenotype, as shown in mice 
deficient in T reg cells (Fontenot et al., 2003; Hori et al., 
2003; Khattri et al., 2003; Lin et al., 2007). Consistently, 
knock-in mice homozygous for a single tyrosine mutation in 
LAT  (Y136F),  which  impairs  PLC1  activation,  develop 
signs of autoimmune disease (Aguado et al., 2002; Sommers 
et al., 2002), which is attributed to impaired negative selec-
tion and T reg cells (Sommers et al., 2005; Koonpaew et al., 
2006). Despite the similarities between LAT (Y136F) knock-
in and Cre/PLC1fl/ mice, these two mutant mice display 
several significant differences. First, lymphoproliferative dis-
order, particularly of CD4+ T cells in LAT (Y136F) knock-in 
mice was in contrast to the severe lymphopenia, particularly 
of CD4+ T cells in Cre/PLC1fl/ mice. Second, CD4+  
T cells from LAT (Y136F) knock-in mice exhibit substantial 
IL-4  production  without  in  vitro  differentiation,  whereas 
those from Cre/PLC1fl/ mice do not produce IL-4. Lastly, 
T cells derived from LAT (Y136F) knock-in mice have normal 
ERK activation, whereas those from Cre/PLC1fl/ mice have 
markedly impaired ERK activation. These differences empha-
size that Y136F mutation in LAT is not equivalent to the dele-
tion of PLC1. Cre/PLC1fl/ mice are unique in uncovering 
the biological function of PLC1 in T cells. The impaired func-
tion of PLC1-deficient T reg cells is likely attributed to defec-
tive TCR-mediated Ca2+ flux and NFAT activation, because   
T cells deficient for STIM1 and STIM2 also displayed impair-
ment of T reg functions (Oh-Hora et al., 2008). In addition,   
T reg function is mediated by an interaction between NFAT 
and FOXP3, disruption of which substantially inhibited T reg 
suppressive function (Wu et al., 2006).
PLC1 deficiency affects the development of CD4+  
T cells more profoundly than that of CD8+ T cells, resulting 
in lower CD4/CD8 ratio in both the thymus and periphery 
of Cre/PLC1fl/ mice relative to controls, reminiscent of mice 
lacking both Itk and Rlk (Broussard et al., 2006). Neverthe-
less,  the  CD8SP  thymocytes  in  PLC-deficient  mice  ap-
peared not to be the innate type CD8+ T cells (CD122+) 
developed in the Itk and Rlk double-deficient mice, as they 
were CD122 (unpublished data). In addition, percentages of 
CD4+ T cells were not reduced in the Itk and Rlk double-
deficient  mice  (Broussard  et  al.,  2006).  It  is  possible  that 
CD4+ and CD8+ cells display a different degree of PLC1 
dependence. It is proposed in the kinetic signaling model that 
proper TCR signaling at the thymic DP stage results in posi-
tive selection and a reduction in the intensity of CD8, leading 
to an appearance of the bipotent CD4+CD8lo thymocytes 
(Singer, 2002). Extended TCR signaling in the CD4+CD8lo 
thymocytes, a sign of MHC class II recognition, results in 
Th-POK expression, which in turn leads to differentiation JEM VOL. 207, February 15, 2010  317
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(20 µg/ml) in 200 µl PBS (2% FBS) for 15 min. After washing, the cells were 
resuspended in 1 ml medium and run on a LSRII (BD). Baseline data were 
collected for 30 s, streptavidin (Thermo Fisher Scientific) was added to a fi-
nal concentration of 8 µg/ml to cross-link the TCR, and data were then 
collected by the LSRII for another 9 min.
BrdU incorporation assay. Mice were injected i.p. with 1 mg BrdU in 
200 µl PBS at 12-h intervals for 5 d. Splenocytes were then prepared for 
analysis. The BrdU staining was performed according to the manufacturer’s 
instructions (BD).
AICD. 3 × 106 purified CD4+ peripheral T cells were stimulated with plate-
bound -CD3 (5 µg/ml -CD3 coated) in 1 ml of T cell medium for 2 d, 
and the cells were collected and cultured at 3 × 106 cells/ml in T cell me-
dium in the presence of 30 U/ml IL-2 for an additional day. The cells were 
then collected and further cultured at 106 cells/ml in media alone or stimu-
lated with plate-bound -CD3 (0.01, 0.1, 1, and 5 µg/ml -CD3 coated) 
for 1 d. 24 h later, the cells were collected and stained for CD4 and CD8 and 
resuspended in PBS with 7-AAD (1 µg/ml) and analyzed by FACS.
T reg suppression assay. Naive CD4+ T cells (CD4+CD25, 2 × 104) 
pooled from spleen and lymph node were stimulated with 2 µg/ml -CD3 
in the presence of 8 × 104 irradiated (3000Rad) splenocytes in 200 µl culture 
medium  in  a  round-bottomed  plate.  Indicated  portions  of  FACS-sorted 
CD4+CD25+YFP+ T reg cells from the spleen and lymph nodes of Cre/
YFP/PLC1+/ or Cre/YFP/PLC1fl/ mice were added at the beginning 
of the culture. After 48 h of culture, the cells were pulsed and harvested as 
previously described (Zeng et al., 2008).
T reg transfer experiment. WT T reg cells were sorted based on CD4 
and GFP expression from Foxp3EGFP mice, in which a bicistronic locus en-
coding both Foxp3 and EGFP was under the control of the Foxp3 promoter 
(Haribhai et al., 2007). Each 10-d-old Cre/YFP/PLC1fl/ pup received 
5 × 105 purified WT T reg cells through i.p. injection and were weighed 
and observed for 3 mo afterward.
Statistical analysis. All P values were calculated according to two-tailed 
Student’s t test analysis. Datasets are presented as mean ± SD.
Online supplemental material. Fig. S1 describes strategies for T-lineage– 
specific  deletion  of  PLC1.  Fig.  S2  shows  PLC1  protein  levels  in   
T cells derived from Cre/PLC1fl/ and Cre/YFP/PLC1fl/ and con-
trol mice. Fig. S3 demonstrates that the activated phenotype is not an in-
trinsic phenotype of the PLC1-deficient T cells. Table S1 demonstrates 
that PLC1-deficient T cells are less competitive than WT T cells in the 
periphery.  Online  supplemental  material  is  available  at  http://www.jem 
.org/cgi/content/full/jem.20090880/DC1.
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